在全球人口结构深刻变迁与健康需求持续升级的时代浪潮下,生物医药行业正站在一个前所未有的历史交汇点。它不仅是守护人类健康的基石,更孕育着巨大的投资机遇。当前,板块估值悄然处于历史相对低位,而创新药国际化步伐加快、高端医疗器械国产替代深化、AI技术赋能研发效率革命等多重利好叠加,生物医药板块正迎来价值重估的关键时刻。本文将深度剖析其投资逻辑,探寻未来十年的“黄金机遇”。一、估值探底:安全边际凸显,细分...
Source Link在全球人口结构深刻变迁与健康需求持续升级的时代浪潮下,生物医药行业正站在一个前所未有的历史交汇点。它不仅是守护人类健康的基石,更孕育着巨大的投资机遇。当前,板块估值悄然处于历史相对低位,而创新药国际化步伐加快、高端医疗器械国产替代深化、AI技术赋能研发效率革命等多重利好叠加,生物医药板块正迎来价值重估的关键时刻。本文将深度剖析其投资逻辑,探寻未来十年的“黄金机遇”。一、估值探底:安全边际凸显,细分...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.